{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T05:21:29Z","timestamp":1762665689149,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DOB 769\/1-1"],"award-info":[{"award-number":["DOB 769\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.yjmcc.2006.09.014","type":"journal-article","created":{"date-parts":[[2006,10,25]],"date-time":"2006-10-25T11:29:34Z","timestamp":1161775774000},"page":"51-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["5-Hydroxytryptamine and atrial arrhythmogenesis: A \u201cculprit mechanism\u201d or bystander in patients with chronic atrial fibrillation?"],"prefix":"10.1016","volume":"42","author":[{"given":"Dobromir","family":"Dobrev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.yjmcc.2006.09.014_bib1","first-page":"108","article-title":"Electrical remodeling in atrial fibrillation","volume":"31","author":"Dobrev","year":"2006","journal-title":"Herz Cardiovascular Diseases"},{"key":"10.1016\/j.yjmcc.2006.09.014_bib2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.pharmthera.2005.12.004","article-title":"5-Hydroxytryptamine receptors in the human cardiovascular system","volume":"111","author":"Kaumann","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.yjmcc.2006.09.014_bib3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.yjmcc.2006.08.007","article-title":"Electrophysiological and arrhythmogenic effects of 5-hydroxytryptamine on human atrial cells are reduced in atrial fibrillation","volume":"42","author":"Pau","year":"2007","journal-title":"J. Mol. Cell Cardiol."},{"issue":"8","key":"10.1016\/j.yjmcc.2006.09.014_bib4","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/sj.bjp.0705553","article-title":"Electrophysiological effects of 5-hydroxytryptamine on isolated human atrial myocytes, and the influence of chronic beta-adrenoceptor blockade","volume":"140","author":"Pau","year":"2003","journal-title":"Br. J. Pharmacol."},{"issue":"5\u20136","key":"10.1016\/j.yjmcc.2006.09.014_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/10606820490926115","article-title":"High efficiency activation of L-type Ca2+ current by 5-HT in human atrial myocytes","volume":"10","author":"Di Scala","year":"2004","journal-title":"Recept. Channels"},{"key":"10.1016\/j.yjmcc.2006.09.014_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.yjmcc.2006.06.071","article-title":"Remodeled cardiac calcium channels","author":"Pitt","year":"2006","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.yjmcc.2006.09.014_bib7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s003950170081","article-title":"Atrial L-type Ca2+-channel, \u03b2-adrenoceptor, and 5-hydroxytryptamine type 4 receptor mRNAs in human atrial fibrillation","volume":"96","author":"Grammer","year":"2001","journal-title":"Basic Res. Cardiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2006.09.014_bib8","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/BF00171339","article-title":"L-type calcium channel activity in human atrial myocytes as influenced by 5-HT","volume":"348","author":"Jahnel","year":"1993","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.yjmcc.2006.09.014_bib9","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1161\/01.CIR.0000145659.80212.6A","article-title":"Reduced L-type Ca2+ current density in chronic human atrial fibrillation is associated with increased activity of protein phosphatases","volume":"110","author":"Christ","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2006.09.014_bib10","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/CIRCULATIONAHA.106.636845","article-title":"Molecular determinants of altered Ca2+-handling in human chronic atrial fibrillation","volume":"114","author":"El-Armouche","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2006.09.014_bib11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/01.CIR.103.5.691","article-title":"Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation","volume":"103","author":"Schotten","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2006.09.014_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s003950170065","article-title":"L-type calcium current in atrial myocytes from patients with persistent and non-persistent atrial fibrillation","volume":"96","author":"Skasa","year":"2001","journal-title":"Basic Res. Cardiol."},{"issue":"Pt. 3","key":"10.1016\/j.yjmcc.2006.09.014_bib13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1113\/jphysiol.2003.058529","article-title":"Inositol-1,4,5-trisphosphate-dependent Ca2+ signaling in cat atrial excitation-contraction coupling and arrhythmias","volume":"555","author":"Zima","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.yjmcc.2006.09.014_bib14","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/hh2301.100003","article-title":"Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase A","volume":"89","author":"Antos","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2006.09.014_bib15","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1161\/01.CIR.0000162461.67140.4C","article-title":"Defective cardiac ryanodine receptor regulation during atrial fibrillation","volume":"111","author":"Vest","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2006.09.014_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.yjmcc.2006.06.072","article-title":"Alterations in contractile protein composition and function in human atrial dilatation and atrial fibrillation","author":"Eiras","year":"2006","journal-title":"J. Mol. Cell Cardiol."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282806009229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282806009229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T05:18:58Z","timestamp":1762665538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282806009229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0022282806009229"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2006.09.014","relation":{},"ISSN":["0022-2828"],"issn-type":[{"type":"print","value":"0022-2828"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-Hydroxytryptamine and atrial arrhythmogenesis: A \u201cculprit mechanism\u201d or bystander in patients with chronic atrial fibrillation?","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2006.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}